ALSO READSun Pharma gains after settling patent litigation for generic Sun Pharma skids after fire incident at Gujarat plant Sun Pharma gains after USFDA accepts new drug application Sun Pharma shares surge nearly 7 pc, mcap rises by Rs 8,935 cr Sun Pharma settles patent litigation with Ironwood, Allergan
Sun Pharmaceutical Industries today reported 75.17 per cent dip in its consolidated net profit at Rs 365.39 crore for the third quarter ended December 31, 2017-18.
The drug major had reported net profit of Rs 1,471.82 crore in the October-December quarter of 2016-17.
Its total revenue from operations stood at Rs 6,653.23 crore during the third quarter of 2017-18. It was Rs 7,925.11 crore during the same period of previous fiscal.
Shares of the company today ended 2.53 per cent down at Rs 574.45 on the BSE.